Nintedanib and immunomodulatory therapies in progressive fibrosing interstitial lung diseases

by Vincent Cottin, Luca Richeldi, Ivan Rosas, Maria Otaola, Jin Woo Song, Sara Tomassetti, Marlies Wijsenbeek, Manuela Schmitz, Carl Coeck, Susanne Stowasser, Rozsa Schlenker-Herceg, Martin Kolb, the INBUILD Trial Investigators
Published 2021-03-01

Serum endostatin levels are associated with diffusion capacity and with tuberous sclerosis- associated lymphangioleiomyomatosis

by Anthony M. Lamattina, Sergio Poli, Pranav Kidambi, Shefali Bagwe, Andrew Courtwright, Pierce H. Louis, Shikshya Shrestha, Benjamin Stump, Hilary J. Goldberg, Elizabeth A. Thiele, Ivan Rosas, Elizabeth P. Henske, Souheil El-Chemaly
Published 2019-03-01

The characterisation of interstitial lung disease multidisciplinary team meetings: a global study

by Luca Richeldi, Naomi Launders, Fernando Martinez, Simon L.F. Walsh, Jeffrey Myers, Bonnie Wang, Mark Jones, Alison Chisholm, Kevin R. Flaherty, REG IPF/ILD Working Group collaborators:, Aileen David-Wang, Antonio Morais, Arata Azuma, Bruno Crestani, Carlo Vancheri, Carole Youakim, Charlene D. Fell, Christopher J. Ryerson, Demosthenes Bouros, Elisabeth Bendstrup, Ferran Morell, Francesco Bonella, Ganesh Raghu, George Christoff, Giovanni Ferrara, Ian Glaspole, Ivan Rosas, Jürgen Behr, Kaissa DeBoer, Katerina M. Antoniou, Keertan Dheda, Kevin Brown, Lurdes Planas-Cerezales, Magnus Sköld, Manuela Funke, Maria Molina-Molina, Mariano Mazzei, Martin Kolb, Moises Selman, Paola Rottoli, Paolo Spagnolo, Pilar Rivera-Ortega, Sergey Avdeev, Silvia Quandrelli, Tamera J. Corte, Toby M. Maher, Vincent Cottin, Wim Wuyts, Zuo Jun Xu
Published 2019-04-01